Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.30 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29926635 | 0.77 | SMN1; SMN2 (0.42) | PKMSMN1; SMN2HCAR2DHODH | |
| SCHEMBL7862999 | 0.77 | SMN1; SMN2 (0.42) | PKMSMN1; SMN2HCAR2DHODH | |
| SCHEMBL10981379 | 0.74 | SMN1; SMN2 (0.39) | PKMSMN1; SMN2HCAR2DHODH | |
| SCHEMBL5394517 | 0.71 | LDHA (0.35) | PKMSMN1; SMN2HCAR2 | |
| SCHEMBL11936748 | 0.71 | SMN1; SMN2 (0.41) | PKMSMN1; SMN2HCAR2DHODH | |
| SCHEMBL10386157 | 0.70 | SMN1; SMN2 (0.38) | PKMSMN1; SMN2HCAR2 | |
| SCHEMBL23609662 | 0.70 | HCAR2 (0.38) | PKMSMN1; SMN2HCAR2DHODH | |
| SCHEMBL31542027 | 0.69 | SMN1; SMN2 (0.41) | SMN1; SMN2 | |
| SCHEMBL7596490 | 0.69 | SMN1; SMN2 (0.37) | PKMSMN1; SMN2HCAR2 | |
| SCHEMBL7863497 | 0.69 | GLRA3 (0.38) | PKMSMN1; SMN2TAS1R3TAS1R1TAS1R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312366-B2 | Preparation of one intermediate for pyrethroids | JIANGSU YANGONG CHEMICAL CO., LTD. (CN) | 2007-12-25 | — | — | US | disclosed |
| US-20070055075-A1 | Preparation of one intermediate for pyrethroids | JIANGSU YANGNONG CHEMICAL CO., LTD. (CN) | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070055075-A1 | Preparation of one intermediate for pyrethroids | CYP4F2, CYP4F3, CYP4F12 | PKM 2915/4885SMN1; SMN2 3131/4885HCAR2 2664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.